Expression of Bcl-2 family proteins and associated clinicopathologic factors predict survival outcome in patients with oral squamous cell carcinoma

被引:58
作者
Camisasca, Danielle Resende [1 ]
Honorato, Julia [1 ]
Bernardo, Vagner [1 ]
da Silva, Licinio Esmeraldo [2 ]
da Fonseca, Eliene Carvalho [3 ]
Silvestre de Faria, Paulo Antonio [4 ]
Dias, Fernando Luiz [5 ]
Chaves Lourenco, Simone de Queiroz [1 ]
机构
[1] Univ Fed Fluminense, Pathol Grad Program, BR-24030210 Niteroi, RJ, Brazil
[2] Univ Fed Fluminense, Dept Stat, Math Inst, BR-24020140 Niteroi, RJ, Brazil
[3] Univ Fed Fluminense, Dept Pathol, Sch Med, Hosp Univ Antonio Pedro, BR-24033900 Niteroi, RJ, Brazil
[4] Natl Canc Inst, Div Pathol, BR-20220400 Rio De Janeiro, Brazil
[5] Natl Canc Inst, Dept Head & Neck Surg, BR-20230130 Rio De Janeiro, Brazil
关键词
Mouth neoplasms; Squamous cell carcinoma; Prognosis; Survival analysis; Immunohistochemistry; Bcl-2-associated X protein; C-Bcl-2; proteins; Bcl-X protein; IN-VIVO; BAX; HEAD; CANCER; NECK; P53; TONGUE;
D O I
10.1016/j.oraloncology.2008.05.021
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aims of this study were to assess the expression levels of three proteins involved in apoptosis-Bcl-2, Bcl-X, and Bax-and evaluate their relationship with clinicopathologic features and survival in oral squamous cell carcinoma (OSCC). Immunohistochemistry was used to evaluate protein expression in 53 primary OSCCs treated by radical surgery with free margins at a single institution in 1999. Histologic specimens were graded and analyzed for perineural invasion, lymphocytic infiltrate, and pattern of invasion. Digital image analysis was performed to quantify immunostaining. Survival was analyzed using the Kaplan-Meier method and Cox's proportional hazard model. Cancer-specific 5-year survival (CSS) was 61% (56% overall survival (OS), and 51% disease-free interval (DFI)). Kaplan-Meier analysis identified pathologic stage (p = 0.0007 log-rank test, OS), negative nodes status (pN) (p < 0.0001, log-rank test, OS), presence of lymphocytic infiltrate (p = 0.0084, log-rank test, OS), and high Bax expression (p = 0.025, log-rank test, OS) to each be associated with both better OS and CSS. Tongue tumors (p=0.0179, log-rank test), worst pattern of invasion (p = 0.0293, log-rank test), lack of lymphocytic infiltrate (p = 0.0328, log-rank test), perineural invasion (p = 0.0448, log-rank test), poorly differentiated tumors (p = 0.0318, log-rank test), and low Bcl-X expression (p = 0.044, log-rank test) were all associated with a low DFI. Cox regression found pN, lymphocytic infiltrate, and Bax expression to be independent prognostic factors for OS and CSS, whereas lymphocytic response and tongue tumors were predictors of DFI. Bcl-2 expression emerged as an independent marker of favorable CSS. Lymphocytic infiltrate was the most meaningful histopathologic parameter in survival analysis, whereas expression of Bcl-2 family members seems to be an important marker of a favorable prognosis in OSCC. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:225 / 233
页数:9
相关论文
共 31 条
[1]   Early stage carcinoma of oral tongue: prognostic factors for local control and survival [J].
Al-Rajhi, N ;
Khafaga, Y ;
El-Husseiny, J ;
Saleem, M ;
Mourad, W ;
Al-Otieschan, A ;
Al-Amro, A .
ORAL ONCOLOGY, 2000, 36 (06) :508-514
[2]  
[Anonymous], 2005, World Health Organization Classification of Tumours: Pathology and Genetics of Head and Neck Tumours
[3]   Prognostic and predictive factors in oral squamous cell cancer:: important tools for planning individual therapy? [J].
Bettendorf, O ;
Piffkò, J ;
Bànkfalvi, A .
ORAL ONCOLOGY, 2004, 40 (02) :110-119
[4]  
Brandwein-Gensler A, 2005, AM J SURG PATHOL, V29, P167
[5]  
*BRAZ MIN OF HLTH, 2007, EST 2008 BRAZ CANC I
[6]   Predictive value of p53, Bcl-2, and Bax in advanced head and neck carcinoma [J].
Casado, S ;
Forteza, J ;
Dominguez, S ;
Abad, MT ;
Perez, I ;
Intxaurbe, I ;
del Campo, JM ;
Lopez, R .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (06) :588-590
[7]   Dysregulated expression of bcl-2 and bax in oral carcinomas:: evidence of posttranscriptional control [J].
Chen, Y ;
Kayano, T ;
Takagi, M .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2000, 29 (02) :63-69
[8]   Conversion of Bcl-2 to a Bax-like death effector by caspases [J].
Cheng, EHY ;
Kirsch, DG ;
Clem, RJ ;
Ravi, R ;
Kastan, MB ;
Bedi, A ;
Ueno, K ;
Hardwick, JM .
SCIENCE, 1997, 278 (5345) :1966-1968
[9]  
de Vicente JC, 2006, J ORAL PATHOL MED, V35, P140
[10]   Bcl-XL is qualitatively different from and ten times more effective than Bcl-2 when expressed in a breast cancer cell line [J].
Fiebig, Aline A. ;
Zhu, Weijia ;
Hollerbach, Catherine ;
Leber, Brian ;
Andrews, David W. .
BMC CANCER, 2006, 6 (1)